ID: ALA3678078

Max Phase: Preclinical

Molecular Formula: C17H28N2O3

Molecular Weight: 308.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCOc1cc(CCNCC(=O)N(C)C)ccc1OC

Standard InChI:  InChI=1S/C17H28N2O3/c1-5-6-11-22-16-12-14(7-8-15(16)21-4)9-10-18-13-17(20)19(2)3/h7-8,12,18H,5-6,9-11,13H2,1-4H3

Standard InChI Key:  ZEBKYEICOYLYGX-UHFFFAOYSA-N

Associated Targets(non-human)

Monoamine oxidase B 2209 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 308.42Molecular Weight (Monoisotopic): 308.2100AlogP: 2.09#Rotatable Bonds: 10
Polar Surface Area: 50.80Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.63CX LogP: 1.95CX LogD: 0.69
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.67Np Likeness Score: -0.79

References

1.  (2015)  Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators, 

Source

Source(1):